Cerus
CERS
#7526
Rank
C$0.56 B
Marketcap
C$2.93
Share price
5.53%
Change (1 day)
16.31%
Change (1 year)

P/E ratio for Cerus (CERS)

P/E ratio as of December 2025 (TTM): -26.3

According to Cerus's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -26.25. At the end of 2024 the company had a P/E ratio of -14.0.

P/E ratio history for Cerus from 2001 to 2025

PE ratio at the end of each year

Year P/E ratio Change
2024-14.0
2022-14.6-33.54%
2021-22.014.28%
2020-19.2136.86%
2019-8.12-29.57%
2018-11.590.91%
2017-6.04-13.97%
2016-7.02-35.61%
2015-10.9-13.89%
2014-12.725.56%
2013-10.1-4.32%
2012-10.5

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
Haemonetics
HAE
24.3-192.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-0.0171-99.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Boston Scientific
BSX
51.7-296.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Utah Medical Products
UTMD
15.8-160.12%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.